What is the dosing for fabhalta?

See the DrugPatentWatch profile for fabhalta

What is the typical dosing for fabhalta?

Fabhalta is an alpha-glucosidase inhibitor used to slow the movement of stomach and intestine contents to help manage postprandial glucose levels in patients with type 1 diabetes and type 2 diabetes mellitus.

The recommended dosage of fabhalta can vary depending on the individual patient's requirements and response to treatment.

Typical dosing regimen:

The typical dosing regimen for fabhalta involves taking one 250-mg tablet orally three times a day with each main meal, at the start of meals.

What happens if patients miss a dose?

If a patient misses a dose of fabhalta, they should take the missed dose as soon as they remember, unless it is almost time for their next scheduled dose. In that case, the patient should skip the missed dose and continue with their regular dosing schedule.

Potential interaction with other diabetes medications:

Fabhalta can be used in combination with other diabetes medications, such as insulin or sulfonylureas, but the dosage of fabhalta may need to be adjusted depending on the patient's individual response to treatment.

Monitoring patient response:

Patients taking fabhalta should have their glucose levels closely monitored, especially during the initial treatment period, to adjust their dosing regimen as needed.

For more information on the dosing and usage of fabhalta, refer to the prescribing information or consult with a healthcare professional.

Sources:
[1] Novo Nordisk. (2022). Fabhalta (allegro) Dosage and Administration. Retrieved from https://www.novonordisk.com/countries/usa/pi/dmpdf/aleg.pdf
[2] DrugPatentWatch.com. Fabhalta. Retrieved from https://www.drugpatentwatch.com/drugs/fabhalta